Characteristics and healthcare costs of patients with fibromyalgia syndrome

International Journal of Clinical Practice

Volumn 61, Issue 9, 2007, Pages 1498-1508

  Berger, A ^a   Dukes, E ^b   Martin, S ^b   Edelsberg, J ^a   Oster, G ^a  

^a POLICY ANALYSIS INC PAI   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIMIGRAINE AGENT; ANTIULCER AGENT; BENZODIAZEPINE; BUPIVACAINE; CLONIDINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DIURETIC AGENT; ESTROGEN; HYPNOTIC SEDATIVE AGENT; LIDOCAINE; MONOAMINE OXIDASE INHIBITOR; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TETRACYCLINE DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; UNINDEXED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; COST OF ILLNESS; DATA BASE; FEMALE; FIBROMYALGIA; HEALTH CARE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; MALE; NEUROPATHIC PAIN; PRIORITY JOURNAL; SEX RATIO; UNITED STATES;

ADULT; FEMALE; FIBROMYALGIA; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; SLEEP DEPRIVATION;

EID: 34547754495     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01480.x     Document Type: Article

References (38)

1. Wolfe F. The epidemiology of fibromyalgia. J Musculoskelet Pain 1993 1 : 137 48.
2. Campbell SM, Clark S, Tindall EA et al. Clinical characteristics of fibrositis. I. A 'blinded', controlled study of symptoms and tender points. Arthritis Rheum 1983 26 : 817 24.
3. Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990 33 : 160 72.
4. Crofford LJ, Rowbotham MC, Mease PJ et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005 52 : 1264 73.
5. Arnold LM, Rosen A, Pritchett YL et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005 119 : 5 15.
6. Arnold LM, Lu Y, Crofford LJ et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004 50 : 2974 84.
7. Tofferi JK, Jackson JL, O'Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum 2004 51 : 9 13.
8. Arnold LM, Hess EV, Hudson JI et al. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002 112 : 191 7.
9. Goldenberg D, Mayskiy M, Mossey C et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996 39 : 1852 9.
10. Carette S, Bell MJ, Reynolds WJ et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. Arthritis Rheum 1994 37 : 32 40.
11. Santandrea S, Montrone F, Sarzi-Puttini P et al. A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome. J Int Med Res 1993 21 : 74 80.
12. Russell IJ, Fletcher EM, Michalek JE et al. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: a double-blind, placebo-controlled study. Arthritis Rheum 1991 34 : 552 60.
13. Goldenberg DL. Fibromyalgia: treatment problems. J Musculoskelet Pain 1993 1 : 71 81.
14. Dadabhoy D, Clauw DJ. Therapy insight: Fibromyalgia - a different type of pain needing a different type of treatment. Nat Clin Pract Rheum 2006 2 : 364 72.
15. Dadabhoy D, Clauw DJ. Fibromyalgia: progress in diagnosis and treatment. Curr Pain Headache Rep 2005 9 : 399 404.
16. Rao SG, Clauw DJ. The management of fibromyalgia. Drugs Today 2004 40 : 539 54.
17. Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia: disability and health-care use. Med Care 1996 34 : 924 30.
18. White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 1999 26 : 1577 85.
19. Wolfe F, Anderson J, Harkness D et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997 40 : 1560 70.
20. Penrod JR, Bernatsky S, Adam V et al. Health services costs and their determinants in women with fibromyalgia. J Rheumatol 2004 31 : 1391 8.
21. Robinson RL, Birnbaum HG, Morley MA et al. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol 2003 30 : 1318 25.
22. Hughes G, Martinez C, Myon E et al. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: An observational study based on clinical practice. Arthritis Rheum 2006 54 : 177 83.
23. Boonen A, van den Heuvel R, van Tubergen A et al. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylosis. Ann Rheum Dis 2005 64 : 396 402.
24. World Health Organization. Cancer Pain Relief. Geneva, Switzerland : World Health Organization, 1996.
25. Brant JM. Cancer-related neuropathic pain. Nurse Pract Forum 1998 9 : 154 62.
26. Kanner R. Diagnosis and management of neuropathic pain in patients with cancer. Cancer Invest 2001 19 : 324 33.
27. George RM, Ahmedzai SH. The management of neuropathic pain in cancer: Clinical guidelines for the use of adjuvant analgesics. Indian J Cancer 2000 37 : 4 9.
28. Allen RR. Neuropathic pain in the cancer patient. Neuropathic Pain Syndr 1998 16 : 869 87.
29. Katz N. Neuropathic pain in cancer and AIDS. Clin J Pain 2000 16 : S41 8.
30. Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988 33 : 11 23.
31. Cohen KL, Harris S. Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch Intern Med 1987 147 : 1442 4.
32. Ripamonti C, Dickerson ED. Strategies for the treatment of cancer pain in the new millennium. Drugs 2001 61 : 955 77.
33. Farrar JT, Portenoy RK. Neuropathic cancer pain: the role of adjuvant analgesics. Oncology 2001 15 : 1435 45.
34. Oster G, Berger A, Dukes E et al. Use of potentially inappropriate pain-related medications in older adults with painful neuropathic disorders. Am J Geriatr Pharmacother 2004 2 : 163 70.
35. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004 5 : 143 9.
36. Berger A, Dukes E, Mercadante S, Oster G. Use of antiepileptics and tricyclic antidepressants in cancer patients with neuropathic pain. Eur J Cancer Care 2006 15 : 138 45.
37. SAS® Proprietary Software. Release 9.1. Cary, NC : SAS Institute Inc., 2004.
38. Oliver K, Cronan TA, Walen HR, Tomita M. Effects of social support and education on health care costs for patients with fibromyalgia. J Rheumatol 2001 28 : 2711 9.